{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:00:47Z","timestamp":1786118447183,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>Cartilage hair hypoplasia\u2013anauxetic dysplasia (CHH-AD) spectrum disorders are rare skeletal dysplasias caused by pathogenic variants in RMRP, associated with immune dysfunction and cancer predisposition. While non-Hodgkin lymphoma is more commonly seen, Hodgkin lymphoma (HL) is rarely reported, and its management in this setting remains unclear. We describe 2 siblings with genetically confirmed CHH-AD who developed relapsed\/refractory EBV-positive classic HL. Both presented with short stature, atopy, recurrent infections, and elevated IgE. The brother was diagnosed with stage IV disease, and the sister with stage IIB. Despite receiving frontline chemotherapy, both relapsed within a year. Salvage therapy with gemcitabine\/vinorelbine induced metabolic responses, followed by radiotherapy and consolidation with brentuximab vedotin. Autologous transplant was considered but declined by the family due to perceived risks. At 30 months follow-up, both remain in complete remission. Genetic testing confirmed a shared homozygous pathogenic RMRP variant. These cases expand the oncologic spectrum of CHH-AD to include HL, highlight the risk of aggressive disease and early relapse, and demonstrate that durable remission may be achieved without transplantation when consolidation with targeted therapy is feasible. Early recognition of CHH-AD features in HL patients may allow risk-adapted therapy and informed genetic counseling.<\/jats:p>","DOI":"10.1097\/mph.0000000000003158","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T16:00:15Z","timestamp":1767024015000},"page":"e91-e96","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Refractory\/Relapsed Hodgkin Lymphoma in Cartilage Hair Hypoplasia\u2013Anauxetic Dysplasia Spectrum: Long-term HSCT-free Remission in 2 Pediatric Siblings"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1805-1331","authenticated-orcid":false,"given":"Syed Ibrahim","family":"Bukhari","sequence":"first","affiliation":[{"name":"Department of Oncology, Aga Khan University, Karachi, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahr","family":"Yazdani","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Fadoo","sequence":"additional","affiliation":[{"name":"Department of Oncology, Aga Khan University, Karachi, Sindh, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"R2-20260225","doi-asserted-by":"crossref","first-page":"0","DOI":"10.5812\/jpr.194","article-title":"Clinical features and management of cartilage-hair hypoplasia: a narrative review","volume":"3","author":"Shiasi Arani","year":"2015","journal-title":"J Pediatr Rev"},{"key":"R3-20260225","doi-asserted-by":"crossref","first-page":"e37247","DOI":"10.1097\/MD.0000000000037247","article-title":"Cartilage-hair hypoplasia\u2013anauxetic dysplasia spectrum disorders harboring RMRP mutations in two Korean children: a case report","volume":"103","author":"Park","year":"2024","journal-title":"Medicine"},{"key":"R4-20260225","doi-asserted-by":"crossref","first-page":"1004694","DOI":"10.3389\/fimmu.2022.1004694","article-title":"Lymphomas in cartilage-hair hypoplasia\u2014\u0101 case series of 16 patients reveals advanced stage DLBCL as the most common form","volume":"13","author":"Kukkola","year":"2022","journal-title":"Front Immunol"},{"key":"R5-20260225","doi-asserted-by":"crossref","first-page":"e12913","DOI":"10.1111\/sji.12913","article-title":"Immunodeficiency in cartilage-hair hypoplasia: pathogenesis, clinical course and management","volume":"92","author":"Vakkilainen","year":"2020","journal-title":"Scand J Immunol"},{"key":"R6-20260225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(21)00470-8","article-title":"Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial","volume":"23","author":"Mauz-K\u00f6rholz","year":"2022","journal-title":"Lancet"},{"key":"R7-20260225","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1097\/HS9.0000000000000329","article-title":"Risk and response adapted treatment guidelines for managing first relapsed and refractory classical hodgkin lymphoma in children and young people. recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group","volume":"4","author":"Daw","year":"2020","journal-title":"HemaSphere"},{"key":"R8-20260225","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1080\/10428194.2020.1817434","article-title":"Response rates, long term outcomes and toxicity profile of gemcitabine and vinorelbine based outpatient chemotherapy regimen in primary progressive and relapsed childhood Hodgkin lymphoma","volume":"61","author":"Jan","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"R9-20260225","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1200\/JCO.2008.20.3778","article-title":"Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin\u2019s disease: a children\u2019s oncology group report","volume":"27","author":"Cole","year":"2009","journal-title":"J Clin Oncol"},{"issue":"Supplement_1","key":"R10-20260225","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/ajcp\/aqae129.207","article-title":"Epstein Barr virus positive mucocutaneous ulcer versus classic Hodgkin lymphoma: challenges in diagnosis","volume":"162","author":"Hamdan","year":"2024","journal-title":"Am J Clin Pathol"},{"key":"R11-20260225","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/milmed\/149.5.280","article-title":"Hodgkin\u2019s lymphoma in achild with cartilage-hair hypoplasia: case report","volume":"149","author":"Roberts","year":"1984","journal-title":"Mil Med"},{"key":"R12-20260225","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ajmg.1320440432","article-title":"Cartilage-hair-hypoplasia and Hodgkin disease","volume":"44","author":"Gorlin","year":"1992","journal-title":"Am J Med Genet"},{"key":"R13-20260225","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/ajmg.a.32478","article-title":"Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma","volume":"146A","author":"Taskinen","year":"2008","journal-title":"Am J Med Genet A"},{"key":"R14-20260225","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10875-024-01714-9","article-title":"Validation of risk factors for early mortality in cartilage-hair hypoplasia","volume":"44","author":"Vakkilainen","year":"2024","journal-title":"J Clin Immunol"},{"key":"R15-20260225","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3389\/fimmu.2019.01581","article-title":"A 30-year prospective follow-up study reveals risk factors for early death in cartilage-hair hypoplasia","volume":"10","author":"Vakkilainen","year":"2019","journal-title":"Front Immunol"},{"key":"R16-20260225","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/15476286.2018.1518854","article-title":"Identification of host RNAs that interact with EBV noncoding RNA EBER2","volume":"15","author":"Nanni","year":"2018","journal-title":"RNA Biol"},{"key":"R17-20260225","doi-asserted-by":"crossref","first-page":"e70501","DOI":"10.1002\/jmv.70501","article-title":"EBV Latency Programs: molecular and epigenetic regulation and its role in disease pathogenesis","volume":"97","author":"Lyu","year":"2025","journal-title":"J Med Virol"},{"key":"R18-20260225","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/1078-0432.CCR-20-2574","article-title":"Hematopoietic stem cell transplantation positively affects the natural history of cancer in Nijmegen breakage syndrome","volume":"27","author":"Wolska-Kusnierz","year":"2021","journal-title":"Clin Cancer Res"},{"key":"R19-20260225","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.2014.56.5101","article-title":"Incidence, presentation, and prognosis of malignancies in ataxia-telangiectasia: a report from the French national registry of primary immune deficiencies","volume":"33","author":"Suarez","year":"2015","journal-title":"J Clin Oncol"},{"key":"R20-20260225","first-page":"491","article-title":"Treatment of lymphoid malignancies in patients with ataxia-telangiectasia","volume":"31","author":"Sandoval","year":"1998","journal-title":"Pediatr Blood Cancer"},{"key":"R21-20260225","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/pbc.21789","article-title":"Non-Hodgkin lymphoma (NHL) in children with Nijmegen breakage syndrome (NBS)","volume":"52","author":"Dembowska-Baginska","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R22-20260225","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2141.2011.08863.x","article-title":"Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey","volume":"155","author":"Bienemann","year":"2011","journal-title":"Br J Haematol"},{"key":"R23-20260225","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/pbc.24696","article-title":"Pilot study of modified LMB-based therapy for children with ataxia\u2013telangiectasia and advanced stage high grade mature B-cell malignancies","volume":"61","author":"Sandlund","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R24-20260225","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejmg.2016.05.012","article-title":"Treatment of acute leukemia in children with ataxia telangiectasia (AT)","volume":"59","author":"Schoenaker","year":"2016","journal-title":"Eur J Med Genet"},{"key":"R25-20260225","doi-asserted-by":"crossref","first-page":"140","DOI":"10.20892\/j.issn.2095-3941.2021.0577","article-title":"The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy","volume":"19","author":"Hao","year":"2022","journal-title":"Cancer Biol Med"},{"key":"R26-20260225","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaci.2017.02.016","article-title":"Analysis of clinical and immunologic phenotype in a large cohort of children and adults with cartilage-hair hypoplasia","volume":"140","author":"Kostjukovits","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R27-20260225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of Epstein-Barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"R28-20260225","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/QCO.0b013e328349ac4f","article-title":"The company malaria keeps: how co-infection with Epstein-Barr virus leads to endemic Burkitt lymphoma","volume":"24","author":"Moormann","year":"2011","journal-title":"Curr Opin Infect Dis"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:03:38Z","timestamp":1786032218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003158","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"2025-09-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}